How Hereditary Diseases Are Passed From One Generation to Another

Hereditary diseases travel from parent to child through DNA, but they do not all travel the same route. Some conditions follow predictable paths that a family can trace across generations on a simple chart. Others hide for decades, skip generations entirely, get worse each time they appear, or depend on which parent passed the gene along. Understanding these different routes matters because the inheritance pattern determines how likely a child is to be affected, which family members should be tested, and what reproductive options exist.

Dominant Conditions and the Fifty-Fifty Coin Flip

The simplest pattern to spot is autosomal dominant inheritance. A single copy of a changed gene, inherited from either parent, is enough to cause disease. If one parent carries a dominant disease variant, each pregnancy carries roughly a one-in-two chance of passing it on. Conditions like Huntington disease, Marfan syndrome, and many forms of hereditary cancer syndromes follow this route. Because affected individuals usually have at least one affected parent, these conditions tend to show up in every generation of a family tree, making them relatively straightforward to trace through pedigrees.¹

That said, “dominant” does not always mean “obvious.” Some dominant conditions show reduced penetrance, meaning a person can carry the gene variant and never develop symptoms. When that happens, a disease appears to skip a generation. The grandchild of an affected person develops the condition even though their parent seemed healthy. The gene was there the whole time; it just did not produce visible effects in that particular carrier.

Recessive Conditions and the Hidden Carrier Problem

Autosomal recessive diseases require two copies of the changed gene, one from each parent. Carriers who have just one copy are typically healthy, so neither parent may know they harbor the variant. Cystic fibrosis, sickle cell disease, and phenylketonuria all follow this pattern. Two carrier parents face a one-in-four chance with each pregnancy of having an affected child.

What surprises most people is how many recessive disease variants the average person silently carries. A study that sequenced 104 unrelated individuals found an average carrier burden of about three severe childhood recessive mutations per person, with some carrying as many as seven.² Most of the time this causes no harm because the other copy of the gene works fine, and two unrelated people are unlikely to carry variants in the same gene. But when both parents happen to be carriers for the same condition, the math shifts dramatically.

When the X Chromosome Is Involved

Some diseases are encoded on the X chromosome rather than on one of the 22 non-sex chromosomes. Because males have only one X (paired with a Y), a single recessive variant on their X chromosome has no healthy backup copy to compensate. This is why X-linked recessive conditions like hemophilia and red-green color blindness are far more common in men. Red-green color blindness, for example, affects roughly 8% of males but only about 0.5% of females.³

The classic teaching is that women are safe from X-linked recessive diseases because their second X chromosome provides a working copy. That is an oversimplification. Early in female embryonic development, one X chromosome in every cell is randomly silenced through a process called X-inactivation. If the X carrying the healthy copy gets shut off in too many of the relevant cells, a female carrier can develop symptoms. This phenomenon explains why some women who carry X-linked variants for conditions like muscular dystrophy or intellectual disability end up mildly or even severely affected, not just silently carrying the gene.⁴

Mitochondrial Inheritance Comes Only From Mom

Your cells contain a tiny second genome inside the mitochondria, the structures that produce energy. Mitochondrial DNA is inherited exclusively from the mother because the egg contributes virtually all of the mitochondria to the embryo. A father with a mitochondrial disease variant cannot pass it to any of his children; a mother with such a variant will pass it to all of hers.⁵

Mitochondrial conditions come with their own unpredictability. Each cell contains hundreds or thousands of copies of mitochondrial DNA, and a person can have a mix of normal and mutated copies, a state called heteroplasmy. Symptoms generally do not appear unless the proportion of mutated copies crosses a threshold, typically somewhere between 60% and 90%.⁶ A mother with moderate heteroplasmy might be mildly symptomatic while one of her children inherits a higher proportion of mutated copies and is severely affected. Another child might inherit a lower proportion and remain healthy. This random sorting during egg formation means siblings can have wildly different disease severity, even though they all inherited the same maternal mitochondrial DNA.

Common Diseases and Polygenic Risk

Heart disease, type 2 diabetes, most psychiatric conditions, and many cancers do not follow any of the neat single-gene patterns described above. Instead, their genetic risk is spread across hundreds or thousands of spots in the genome, each contributing a tiny nudge toward higher or lower risk. These common conditions are polygenic, and the combined burden of all risk variants in a person, together with environmental factors, shapes their individual likelihood of disease.⁷

This creates a very different inheritance picture from single-gene disorders. A parent with heart disease does not pass on “the heart disease gene.” They pass on some combination of many risk-increasing and risk-decreasing variants, reshuffled during reproduction. A child might end up with more risk variants than the parent had, or fewer. Environmental exposures, diet, and physical activity then interact with that genetic hand. Researchers have tried to capture this combined genetic burden into polygenic risk scores, which add up all the small effects. These scores can identify people at elevated risk, but they are probabilistic rather than deterministic. Even at the high end of the score distribution, plenty of people never develop the disease.⁸

Genomic Imprinting and the Parent-of-Origin Effect

For a small but important set of genes, the body only reads the copy from one specific parent. The other copy is chemically silenced through an epigenetic mark placed during egg or sperm formation. This process, called genomic imprinting, means it can matter not just whether you inherited a variant, but which parent you inherited it from.⁹

Prader-Willi syndrome and Angelman syndrome are the textbook examples. Both involve the same region on chromosome 15, but losing the father’s active copy produces Prader-Willi syndrome (characterized by extreme hunger and obesity), while losing the mother’s active copy produces Angelman syndrome (characterized by intellectual disability and movement problems). The same chromosomal deletion leads to two completely different conditions depending on which parent it came from. Disrupted imprinting has also been linked to certain cancers and growth disorders.¹⁰¹¹

When Diseases Get Worse With Each Generation

A handful of hereditary conditions do not just pass from parent to child but get more severe or appear earlier in each successive generation. This phenomenon, called anticipation, is driven by unstable stretches of DNA where a short sequence of letters is repeated many times in a row. Every time the gene is copied during reproduction, the repeat can expand further. The longer the repeat stretch grows, the more damaging it becomes, leading to earlier onset and worse symptoms in the next generation.¹²

Huntington disease, myotonic dystrophy, and fragile X syndrome all involve this kind of repeat expansion. In Huntington disease, a parent with a borderline repeat length might develop symptoms in their fifties, while their child, inheriting an expanded repeat, could become symptomatic in their thirties. The instability tends to be greater when the gene is transmitted through the father in some diseases and through the mother in others, adding another layer of complexity to genetic counseling.

Chromosomal Problems and Maternal Age

Not all hereditary conditions trace to a single gene or even a collection of genes. Sometimes entire chromosomes or large chunks of chromosomes are gained, lost, or rearranged. Down syndrome, the most widely known chromosomal condition, usually results from an extra copy of chromosome 21 arising during egg formation rather than from a gene passed down through the family. The risk rises with maternal age because the protein structures (cohesins) that hold chromosomes together in the egg begin to deteriorate over the decades that eggs sit dormant in the ovary.¹³

Other chromosomal conditions are heritable in a more direct sense. Some people carry balanced translocations, meaning two of their chromosomes have swapped segments. The carrier is usually healthy because all the genetic material is still present, just rearranged. But when that person’s eggs or sperm are made, the shuffled chromosomes can end up in unbalanced combinations, leading to miscarriage or children born with genetic abnormalities.¹⁴ Couples with recurrent pregnancy loss are sometimes found to carry these balanced rearrangements without ever knowing it.

Why Penetrance and Expressivity Complicate Predictions

Even within a single family carrying the same disease-causing variant, outcomes can differ dramatically. Two people with the identical mutation in the BRCA1 gene do not necessarily develop breast cancer at the same age, or at all. This variation is explained by penetrance (whether the disease appears) and expressivity (how severe it is when it does). Both are shaped by additional genetic variants elsewhere in the genome, epigenetic modifications, and environmental exposures.¹⁵

Research across tens of thousands of exomes has shown that common genetic variants can shift the severity of what are supposed to be single-gene conditions. People carrying a variant for a metabolic disorder, for instance, tend to have worse lab values if they also carry a high polygenic risk score for the same metabolic trait.¹⁶ In other words, the background genetic “noise” across the rest of the genome can amplify or dampen a single strong-effect variant. This is one reason genetic test results come with probabilities rather than certainties, and why two siblings with the same mutation can have very different lives.

Reduced penetrance also explains a pattern that puzzles many families: how a disease can appear in a child when neither parent was ever sick. The variant may have been present in a parent whose other genetic and environmental factors prevented it from manifesting. Healthy individuals can harbor surprisingly large numbers of potentially harmful gene variants without any obvious consequences.¹⁷

Mosaicism and the “De Novo” Surprise

Sometimes a child is diagnosed with a genetic condition and testing shows neither parent carries the variant in their blood. The standard explanation is a “de novo” mutation, one that arose fresh in the child. But a growing body of work reveals that many of these apparently new mutations actually trace back to a parent who carries the variant in only a fraction of their cells, particularly in their reproductive cells. This is called parental mosaicism.

In one study of 20 families where a child had an apparently de novo variant, researchers uncovered parental mosaicism in 20% of cases.¹⁸ Other studies have detected low-level mosaicism in fathers’ sperm that was undetectable in their blood, meaning a standard blood test would have missed it entirely.¹⁹ The practical consequence is significant: if a couple has one child with an apparently new mutation, the recurrence risk for future pregnancies may be higher than the near-zero figure that “de novo” implies. Some families with multiple affected pregnancies have turned out to have parental mosaicism lurking beneath standard detection thresholds.²⁰

Why Consanguinity Raises the Stakes

When closely related people have children, the odds that both parents carry the same recessive variant increase sharply, because they share a recent common ancestor who may have carried that variant. Populations with high rates of marriage between relatives tend to see more autosomal recessive diseases, including congenital heart conditions, kidney disorders, and rare blood diseases.²¹ Consanguinity rates vary widely between populations, and these differences directly influence how common certain recessive conditions are in different parts of the world.²²

Historically, early human populations were small enough that mating between relatives was probably unavoidable. As populations grew and became more mobile, average levels of genetic relatedness between partners dropped, and with them the expression of many recessive disorders.²³

Environmental Exposures and Epigenetic Transmission

Hereditary disease is usually thought of as something written in DNA sequence. But growing evidence suggests that environmental exposures can leave chemical marks on DNA (or on the proteins that package it) in ways that alter gene activity without changing the sequence itself. In animal studies, exposure to certain toxicants, including pesticides, plastics, and herbicides, has been shown to promote disease in the great-grandchildren of exposed animals, mediated by changes in DNA methylation patterns in the reproductive cells.²⁴

How much of this applies to humans is still being worked out. The animal experiments involve controlled exposures at specific doses, which is difficult to replicate or verify in human populations. But the principle that parental environment can shape offspring health through non-genetic channels is now well accepted in research circles, even if the details remain contentious.

Carrier Screening Before Pregnancy

One of the most practical tools for managing hereditary disease risk is preconception expanded carrier screening. These tests analyze a person’s DNA for variants linked to hundreds of recessive and X-linked conditions before a pregnancy begins. If both partners turn out to be carriers for the same recessive condition, they can explore options like IVF with genetic testing of embryos, donor gametes, or prenatal diagnosis.²⁵ Current panels can cover well over a thousand genes in a single test.²⁶

For couples already going through IVF who know they carry a specific disease variant, preimplantation genetic testing for monogenic disorders allows embryos to be screened before transfer. Advances in whole-genome amplification and sequencing have made these tests faster and more reliable than earlier methods that required lengthy custom setup for each family.²⁷²⁸

Mitochondrial Replacement and Gene Editing on the Horizon

For mitochondrial diseases, standard genetic testing of embryos is not enough because the proportion of mutated mitochondrial DNA in a single embryo biopsy may not reflect what the child will ultimately carry. A more radical approach, mitochondrial replacement therapy, involves transferring the nuclear DNA from a mother’s egg or embryo into a donor egg that has healthy mitochondria. The resulting child inherits nuclear DNA from both parents but mitochondrial DNA from a third person, the donor.²⁹³⁰ The technique has been approved for clinical use in the United Kingdom but remains restricted or unavailable in most other countries.

Gene editing with tools like CRISPR-Cas9 opens the theoretical possibility of correcting disease-causing variants directly in embryos, which would prevent transmission altogether. The idea of making heritable changes to DNA, germline editing, carries enormous ethical weight because any modifications would be passed on to all future descendants.³¹ As of now, germline editing in humans is banned or heavily restricted in most countries. Somatic gene therapies, which treat the patient’s own body cells without affecting reproductive cells, are already in clinical use for a handful of conditions but do not change what gets passed to the next generation.

Communicating Genetic Risk Within Families

Knowing how a hereditary condition moves through a family is only useful if that information reaches the relatives who need it. Research into family communication of genetic risk consistently finds that the process is anything but straightforward. Decisions about who to tell are shaped by a person’s sense of responsibility, family dynamics, the perceived relevance of the information, and concerns about causing distress.³² Some family members are told promptly; others are kept in the dark, sometimes for years.

For hereditary cancer syndromes, where cascade genetic testing of at-risk relatives can be lifesaving, interventions designed to improve family communication have shown modest success at increasing testing uptake among relatives, even if the effect on communication itself has been harder to measure.³³ Genetic counselors increasingly view the family, not just the patient sitting in front of them, as the unit that needs support. If you receive a diagnosis with implications for your relatives, asking your genetic counselor for a letter or summary designed for family sharing can lower the barrier to what is often an awkward and emotionally charged conversation.